ReP USP - Resultado da busca

Artigo de periodico
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission (2024)
Pedrazzi, João Francisco Cordeiro; Amaral, Danyelle Silva; Issy, Ana C.; Gomes, Felipe Villela ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Pharmacology Biochemistry and Behavior. Unidades: FMRP, FORP
Subjects: CANABINOIDES, NEUROTRANSMISSORES, ESQUIZOFRENIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, v. 245, p. 1-9, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2024.173879. Acesso em: 12 maio 2025.
APA
Pedrazzi, J. F. C., Amaral, D. S., Issy, A. C., Gomes, F. V., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, 245, 1-9. doi:10.1016/j.pbb.2024.173879
NLM
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Vancouver
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Artigo de periodico
Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study (2024)
Pinto, Jairo Vinicius Merege de Mello Cruz; Crippa, José Alexandre de Souza ; Ceresér, Keila Maria; Vianna-Sulzbach, Miréia Fortes; Silveira Júnior, Érico de Moura; Rosa, Gabriel Santana da; Silva, Manoella Guatimuzim Testa da; Hizo, Gabriel Henrique; Medeiros, Leonardo Simão; Oliveira, Carlos Eduardo Santana de; Bristot, Giovana; Campos, Alline Cristina de ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Yatham, Lakshmi N.; Kapczinski, Flávio; Kauer-Sant\2019anna, Márcia
Source: The Canadian Journal of Psychiatry. Unidades: FMRP, ESALQ
Subjects: TRANSTORNO BIPOLAR, HUMOR, DEPRESSÃO, CANNABIS, CANABINOIDES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Jairo Vinicius Merege de Mello Cruz et al. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, v. 69, n. 4, p. 242-251, 2024Tradução . . Disponível em: https://doi.org/10.1177/07067437231209650. Acesso em: 12 maio 2025.
APA
Pinto, J. V. M. de M. C., Crippa, J. A. de S., Ceresér, K. M., Vianna-Sulzbach, M. F., Silveira Júnior, É. de M., Rosa, G. S. da, et al. (2024). Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, 69( 4), 242-251. doi:10.1177/07067437231209650
NLM
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant\2019anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 maio 12 ] Available from: https://doi.org/10.1177/07067437231209650
Vancouver
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant\2019anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 maio 12 ] Available from: https://doi.org/10.1177/07067437231209650
Artigo de periodico
Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice (2024)
Moraes, Rafaela Aparecida Ponciano da Silva de; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: CANABINOIDES, MASTIGAÇÃO, NEURÓGLIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Rafaela Aparecida Ponciano da Silva de et al. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, v. 43, n. 1, p. 1-12, 2024Tradução . . Disponível em: https://doi.org/10.1007/s12640-024-00724-0. Acesso em: 12 maio 2025.
APA
Moraes, R. A. P. da S. de, Hallak, J. E. C., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, 43( 1), 1-12. doi:10.1007/s12640-024-00724-0
NLM
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 maio 12 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Vancouver
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 maio 12 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Parte de monografia/livro
Therapeutic potential of CBD in Autism Spectrum Disorder (2024)
Pedrazzi, João Francisco Cordeiro; Camina, Lucas Hassib ; Ferreira, Frederico R.; Hallak, Jaime Eduardo Cecilio ; Del Bel, Elaine Aparecida ; Crippa, José Alexandre de Souza
Source: International review of neurobiology: cannabidiol in neurology and psychiatry. Unidades: FMRP, FORP
Subjects: TRANSTORNO DO ESPECTRO AUTISTA, CANABINOIDES, ENSAIO CLÍNICO, FARMACOLOGIA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Therapeutic potential of CBD in Autism Spectrum Disorder. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: 10.1016/bs.irn.2024.05.002, 2024. p. 334 . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.002. Acesso em: 12 maio 2025.
APA
Pedrazzi, J. F. C., Camina, L. H., Ferreira, F. R., Hallak, J. E. C., Del Bel, E. A., & Crippa, J. A. de S. (2024). Therapeutic potential of CBD in Autism Spectrum Disorder. In International review of neurobiology: cannabidiol in neurology and psychiatry (p. 334 ). London: 10.1016/bs.irn.2024.05.002. doi:10.1016/bs.irn.2024.05.002
NLM
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002
Vancouver
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002
Artigo de periodico-carta/editorial
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] (2023)
Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, CANNABIS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-0047. Acesso em: 12 maio 2025. , 2023
APA
Crippa, J. A. de S., Guimarães, F. S., Zuardi, A. W., & Hallak, J. E. C. (2023). Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-0047
NLM
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 maio 12 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Vancouver
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 maio 12 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Artigo de periodico
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats (2023)
Cardoso, Gleice Kelli Ribeiro da Silva ; Lopes, Willian Lazarini ; Primini, Eduardo Octaviano; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Garcia-Cairasco, Norberto ; Leite-Panissi, Christie Ramos Andrade
Source: Behavioural Brain Research. Unidades: FMRP, FFCLRP
Subjects: CANNABIS, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, v. 452, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114588. Acesso em: 12 maio 2025.
APA
Cardoso, G. K. R. da S., Lopes, W. L., Primini, E. O., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., et al. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, 452, 1-16. doi:10.1016/j.bbr.2023.114588
NLM
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Vancouver
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Artigo de periodico
Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity (2023)
Souza, Carolina Macêdo de; Maisonnette, Sílvia Soares; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Landeira-Fernandez, J.; Leite-Panissi, Christie Ramos Andrade
Source: Pharmaceuticals. Unidades: FMRP, FFCLRP
Subjects: CANABINOIDES, ANSIEDADE, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Carolina Macêdo de et al. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, v. 16, n. 7, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16071003. Acesso em: 12 maio 2025.
APA
Souza, C. M. de, Maisonnette, S. S., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., Landeira-Fernandez, J., & Leite-Panissi, C. R. A. (2023). Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, 16( 7), 1-15. doi:10.3390/ph16071003
NLM
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2025 maio 12 ] Available from: https://doi.org/10.3390/ph16071003
Vancouver
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2025 maio 12 ] Available from: https://doi.org/10.3390/ph16071003
Artigo de periodico
Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus (2023)
Chaves, Yane Costa; Raymundi, Ana Maria; Waltrick, Ana Paula Farias ; Crippa, José Alexandre de Souza ; Stern, Cristina Aparecida Jark; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Acta Neuropsychiatrica. Unidade: FMRP
Subjects: ANSIEDADE, MEDO, CANNABIS, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica, 2023Tradução . . Disponível em: https://doi.org/10.1017/neu.2023.13. Acesso em: 12 maio 2025.
APA
Chaves, Y. C., Raymundi, A. M., Waltrick, A. P. F., Crippa, J. A. de S., Stern, C. A. J., Cunha, J. M. da, & Zanoveli, J. M. (2023). Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica. doi:10.1017/neu.2023.13
NLM
Chaves YC, Raymundi AM, Waltrick APF, Crippa JA de S, Stern CAJ, Cunha JM da, Zanoveli JM. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus [Internet]. Acta Neuropsychiatrica. 2023 ;[citado 2025 maio 12 ] Available from: https://doi.org/10.1017/neu.2023.13
Vancouver
Chaves YC, Raymundi AM, Waltrick APF, Crippa JA de S, Stern CAJ, Cunha JM da, Zanoveli JM. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus [Internet]. Acta Neuropsychiatrica. 2023 ;[citado 2025 maio 12 ] Available from: https://doi.org/10.1017/neu.2023.13
Artigo de periodico
Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study (2023)
Loureiro, Sonia Regina ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Osório, Flávia de Lima
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: SAÚDE MENTAL, OCUPAÇÕES EM SAÚDE, ESTUDOS LONGITUDINAIS, PANDEMIAS, COVID-19, ESTRESSE PROFISSIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Sonia Regina et al. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1237123. Acesso em: 12 maio 2025.
APA
Loureiro, S. R., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., & Osório, F. de L. (2023). Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1237123
NLM
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 maio 12 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Vancouver
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 maio 12 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Artigo de periodico
Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) (2023)
Osório, Flávia de Lima ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Pereira-Lima, Karina ; Loureiro, Sonia Regina
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: COVID-19, SAÚDE MENTAL, ANSIEDADE, ESTRESSE PROFISSIONAL, PROFISSIONAIS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1026429. Acesso em: 12 maio 2025.
APA
Osório, F. de L., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., Pereira-Lima, K., & Loureiro, S. R. (2023). Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1026429
NLM
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 maio 12 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Vancouver
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 maio 12 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Artigo de periodico
DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression (2023)
Mendonça, Mariana S.; Mangiavacchi, Paula M.; Mendes, Ana V.; Loureiro, Sonia Regina ; Martin-Santos, Rocio ; Glória, Leonardo S.; Marques Júnior, Wilson ; Marco, Silmara Paula Gouvea de ; Kanashiro, Milton M.; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Rios, Álvaro F. L.
Source: Journal of Affective Disorders. Unidade: FMRP
Subjects: DEPRESSÃO, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, GRAVIDEZ, RECEPTORES DE GLICOCORTICOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Mariana S. et al. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression. Journal of Affective Disorders, v. 331, p. 287-299, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2023.03.031. Acesso em: 12 maio 2025.
APA
Mendonça, M. S., Mangiavacchi, P. M., Mendes, A. V., Loureiro, S. R., Martin-Santos, R., Glória, L. S., et al. (2023). DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression. Journal of Affective Disorders, 331, 287-299. doi:10.1016/j.jad.2023.03.031
NLM
Mendonça MS, Mangiavacchi PM, Mendes AV, Loureiro SR, Martin-Santos R, Glória LS, Marques Júnior W, Marco SPG de, Kanashiro MM, Hallak JEC, Crippa JA de S, Rios ÁFL. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression [Internet]. Journal of Affective Disorders. 2023 ; 331 287-299.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.jad.2023.03.031
Vancouver
Mendonça MS, Mangiavacchi PM, Mendes AV, Loureiro SR, Martin-Santos R, Glória LS, Marques Júnior W, Marco SPG de, Kanashiro MM, Hallak JEC, Crippa JA de S, Rios ÁFL. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression [Internet]. Journal of Affective Disorders. 2023 ; 331 287-299.[citado 2025 maio 12 ] Available from: https://doi.org/10.1016/j.jad.2023.03.031
Artigo de periodico
Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans (2023)
Guedes, Erika da Cruz; Erustes, Adolfo Garcia; Leão, Anderson H. F. F; Carneiro, César Alves; Abílio, Vanessa C; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Smaili, Soraya S; Reckziegel, Patricia ; Pereira, Gustavo J. S
Source: Neurochemical Research. Unidades: FCF, FMRP
Subjects: CANABINOIDES, CAENORHABDITIS, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUEDES, Erika da Cruz et al. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, v. 48, n. 8, p. 2390–2405, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11064-023-03905-z. Acesso em: 12 maio 2025.
APA
Guedes, E. da C., Erustes, A. G., Leão, A. H. F. F., Carneiro, C. A., Abílio, V. C., Zuardi, A. W., et al. (2023). Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, 48( 8), 2390–2405. doi:10.1007/s11064-023-03905-z
NLM
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2025 maio 12 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Vancouver
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2025 maio 12 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Artigo de periodico
Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial (2023)
Rossi, Giordano Novak ; Rocha, Juliana Mendes; Osório, Flávia de Lima ; Bouso, José Carlos ; Ona, Genís ; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Bertozi, Giuliana; Crevelin, Eduardo José ; Queiroz, Maria Eugênia Costa ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: Journal of Clinical Psychopharmacology. Unidades: FMRP, FFCLRP, FCF, ESALQ
Subjects: ALUCINOGÊNICOS, CANABINOIDES, COGNIÇÃO SOCIAL, EMOÇÕES, EXPRESSÃO FACIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial. Journal of Clinical Psychopharmacology, v. 43, n. 4, p. 339-349, 2023Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001691. Acesso em: 12 maio 2025.
APA
Rossi, G. N., Rocha, J. M., Osório, F. de L., Bouso, J. C., Ona, G., Silveira, G. de O., et al. (2023). Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial. Journal of Clinical Psychopharmacology, 43( 4), 339-349. doi:10.1097/JCP.0000000000001691
NLM
Rossi GN, Rocha JM, Osório F de L, Bouso JC, Ona G, Silveira G de O, Yonamine M, Bertozi G, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC, Santos RG dos. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2023 ; 43( 4): 339-349.[citado 2025 maio 12 ] Available from: https://doi.org/10.1097/JCP.0000000000001691
Vancouver
Rossi GN, Rocha JM, Osório F de L, Bouso JC, Ona G, Silveira G de O, Yonamine M, Bertozi G, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC, Santos RG dos. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2023 ; 43( 4): 339-349.[citado 2025 maio 12 ] Available from: https://doi.org/10.1097/JCP.0000000000001691
Artigo de periodico-carta/editorial
Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups (2023)
Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ANTICONVULSIVANTES, CANNABIS, CONVULSÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antônio Waldo e CRIPPA, José Alexandre de Souza. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-3377. Acesso em: 12 maio 2025. , 2023
APA
Zuardi, A. W., & Crippa, J. A. de S. (2023). Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-3377
NLM
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2025 maio 12 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377
Vancouver
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2025 maio 12 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377
Artigo de periodico
Assessment of child sexual abuse in victimized women (2023)
Silva, Thiago Dornela Apolinário da ; Brito, Luiz Gustavo Oliveira ; Silva, Jucélio da; Crippa, José Alexandre de Souza ; Lara, Lúcia Alves da Silva
Source: Journal of Sex & Marital Therapy. Unidade: FMRP
Subjects: ABUSO SEXUAL, CRIANÇAS, COMPORTAMENTO PSICOSSEXUAL, ESTRESSE, TRAUMA EMOCIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Thiago Dornela Apolinário da et al. Assessment of child sexual abuse in victimized women. Journal of Sex & Marital Therapy, v. 49, n. 8, p. 1029-1042, 2023Tradução . . Disponível em: https://doi.org/10.1080/0092623X.2023.2242352. Acesso em: 12 maio 2025.
APA
Silva, T. D. A. da, Brito, L. G. O., Silva, J. da, Crippa, J. A. de S., & Lara, L. A. da S. (2023). Assessment of child sexual abuse in victimized women. Journal of Sex & Marital Therapy, 49( 8), 1029-1042. doi:10.1080/0092623X.2023.2242352
NLM
Silva TDA da, Brito LGO, Silva J da, Crippa JA de S, Lara LA da S. Assessment of child sexual abuse in victimized women [Internet]. Journal of Sex & Marital Therapy. 2023 ; 49( 8): 1029-1042.[citado 2025 maio 12 ] Available from: https://doi.org/10.1080/0092623X.2023.2242352
Vancouver
Silva TDA da, Brito LGO, Silva J da, Crippa JA de S, Lara LA da S. Assessment of child sexual abuse in victimized women [Internet]. Journal of Sex & Marital Therapy. 2023 ; 49( 8): 1029-1042.[citado 2025 maio 12 ] Available from: https://doi.org/10.1080/0092623X.2023.2242352
Artigo de periodico-carta/editorial
The use of cannabinoids in clinical psychiatry [Editorial] (2023)
Souza, José Diogo Ribeiro de; Crippa, José Alexandre de Souza
Source: Psychiatric Annals. Unidade: FMRP
Subjects: CANABINOIDES, PSIQUIATRIA, ANSIOLÍTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo Ribeiro de e CRIPPA, José Alexandre de Souza. The use of cannabinoids in clinical psychiatry [Editorial]. Psychiatric Annals. Thorofare, NJ: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3928/00485713-20230519-01. Acesso em: 12 maio 2025. , 2023
APA
Souza, J. D. R. de, & Crippa, J. A. de S. (2023). The use of cannabinoids in clinical psychiatry [Editorial]. Psychiatric Annals. Thorofare, NJ: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3928/00485713-20230519-01
NLM
Souza JDR de, Crippa JA de S. The use of cannabinoids in clinical psychiatry [Editorial] [Internet]. Psychiatric Annals. 2023 ; 53( 6): 239-240.[citado 2025 maio 12 ] Available from: https://doi.org/10.3928/00485713-20230519-01
Vancouver
Souza JDR de, Crippa JA de S. The use of cannabinoids in clinical psychiatry [Editorial] [Internet]. Psychiatric Annals. 2023 ; 53( 6): 239-240.[citado 2025 maio 12 ] Available from: https://doi.org/10.3928/00485713-20230519-01
Artigo de periodico
Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] (2022)
Poli Netto, Omero Benedicto ; Hallak, Jaime Eduardo Cecílio; Rosa e Silva, Júlio César; Crippa, José Alexandre de Souza
Source: Revista Brasileira de Ginecologia e Obstetricia. Unidade: FMRP
Subjects: CANNABIS, ENDOMETRIOSE, FARMACOTERAPIA, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLI NETTO, Omero Benedicto et al. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, v. 44, n. 5, p. 449-451, 2022Tradução . . Disponível em: https://doi.org/10.1055/s-0042-1749430. Acesso em: 12 maio 2025.
APA
Poli Netto, O. B., Hallak, J. E. C., Rosa e Silva, J. C., & Crippa, J. A. de S. (2022). Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, 44( 5), 449-451. doi:10.1055/s-0042-1749430
NLM
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2025 maio 12 ] Available from: https://doi.org/10.1055/s-0042-1749430
Vancouver
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2025 maio 12 ] Available from: https://doi.org/10.1055/s-0042-1749430
Artigo de periodico
Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) (2022)
Souza, José Diogo Ribeiro de; Pacheco, Júlia Cozar; Rossi, Giordano Novak ; Paulo, Bruno O. de; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Santos, Rafael Guimarães dos
Source: Pharmaceutics. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo Ribeiro de et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, v. 14, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122598. Acesso em: 12 maio 2025.
APA
Souza, J. D. R. de, Pacheco, J. C., Rossi, G. N., Paulo, B. O. de, Zuardi, A. W., Guimarães, F. S., et al. (2022). Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, 14, 1-14. doi:10.3390/pharmaceutics14122598
NLM
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2025 maio 12 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Vancouver
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2025 maio 12 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Artigo de periodico
What can we learn from animal models to study schizophrenia? (2022)
Crunfli, Fernanda ; Del Bel, Elaine Aparecida ; Gomes, Felipe Villela ; Teles, Caroline Brandão; Zuccoli, Giuliana S.; Chaves Filho, Adriano J. M.; Vieira, Gabriela Maciel ; Amaral, Danyelle Silva; Crippa, José Alexandre de Souza ; Pedrazzi, João Francisco Cordeiro; Macêdo, Danielle S.
Source: Advances in Experimental Medicine and Biology. Unidades: FMRP, FORP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, GLUTAMATOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUNFLI, Fernanda et al. What can we learn from animal models to study schizophrenia?. Advances in Experimental Medicine and Biology, v. 1400, p. 15-33, 2022Tradução . . Disponível em: https://doi.org/10.1007/978-3-030-97182-3_2. Acesso em: 12 maio 2025.
APA
Crunfli, F., Del Bel, E. A., Gomes, F. V., Teles, C. B., Zuccoli, G. S., Chaves Filho, A. J. M., et al. (2022). What can we learn from animal models to study schizophrenia? Advances in Experimental Medicine and Biology, 1400, 15-33. doi:10.1007/978-3-030-97182-3_2
NLM
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2025 maio 12 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Vancouver
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2025 maio 12 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Artigo de periodico
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters (2022)
Crippa, José Alexandre de Souza ; Pereira Junior, Luiz C.; Pereira, Lívia C.; Zimmermann, Patrícia M.; Brum Júnior, Liberato; Rechia, Letícia Mello; Dias, Isabella Caroline da Silva; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Queiroz, Regina Helena Costa; Zuardi, Antonio Waldo
Source: Brazilian Journal of Psychiatry. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, FARMACOTERAPIA, FARMACODINÂMICA, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, v. 44, n. 1, p. 15-20, 2022Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1684. Acesso em: 12 maio 2025.
APA
Crippa, J. A. de S., Pereira Junior, L. C., Pereira, L. C., Zimmermann, P. M., Brum Júnior, L., Rechia, L. M., et al. (2022). Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, 44( 1), 15-20. doi:10.1590/1516-4446-2020-1684
NLM
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2025 maio 12 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Vancouver
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2025 maio 12 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration